Technical Analysis for AGN - Allergan, Inc.
|Grade||Last Price||% Change||Price Change|
AGN closed up 0.99 percent on Monday, June 26, 2017, on 77 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Trend Table & Recent Alerts
|See historical AGN trend table...|
|Date||Alert Name||Type||% Chg|
|Jun 26||Upper Bollinger Band Walk||Other||0.00%|
|Jun 23||Upper Bollinger Band Walk||Other||0.99%|
|Jun 22||Upper Bollinger Band Walk||Other||0.73%|
|Jun 21||Upper Bollinger Band Walk||Other||1.85%|
|Jun 20||Upper Bollinger Band Walk||Other||4.31%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
- Earnings date: 2017-05-09
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Is AGN a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more AGN news...
|52 Week High||259.7309|
|52 Week Low||183.4157|
|200-Day Moving Average||224.8212|
|50-Day Moving Average||233.256|
|20-Day Moving Average||233.794|
|10-Day Moving Average||239.725|
|Average True Range||3.4588|
|Chandelier Exit (Long, 3 ATRs)||239.8736|
|Chandelier Exit (Short, 3 ATRs)||232.2764|
|Upper Bollinger Band||249.0511|
|Lower Bollinger Band||218.5369|
|Percent B (%b)||1.0|
|MACD Signal Line||2.2528|